A regulatory bias against taking oral anti-cancer medications with food places patients at risk for an overdose and forces them to flush away costly medicines, argues an authority on cancer-drug dosing. It could be safer, more effective and cost-efficient if the cancer drugs that are better absorbed with food were studied and, when appropriate, prescribed to be taken with food.